87233-62-3
87233-62-3 結(jié)構(gòu)式
基本信息
富馬酸依美達斯汀
依美斯汀二富馬酸鹽
富馬酸依美斯汀 EP標準品
富馬酸依美斯汀 USP標準品
1-(2-乙氧基乙基)-2-(4-甲基-1,4-二氮雜環(huán)庚-1-基)-1H-苯并[D]咪唑 二富馬酸鹽
1-(2-乙氧基乙基)-2-(六氫-4-甲基-1H-1,4-二氮雜卓-1-基)-1H-苯并咪唑二富馬酸鹽
kb2413
Remicut
Emadine
kb-2413
kg-2413
Rapimine
AL 3432A
ly188695
arate(1:2)
物理化學性質(zhì)
安全數(shù)據(jù)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2024/11/08 | S5647 | 富馬酸依美斯汀 Emedastine Difumarate | 87233-62-3 | 5mg | 795.16元 |
| 2024/11/08 | S5647 | 富馬酸依美斯汀 Emedastine Difumarate | 87233-62-3 | 25mg | 2375.53元 |
| 2022/07/01 | E0936 | 富馬酸依美斯汀 Emedastine Difumarate | 87233-62-3 | 1g | 2655元 |
常見問題列表
| Target | Value |
|
Histamine H1 receptor
() |
Emedastine difumarate inhibits histamine H
2
receptor (K
i
=49067 nM) and histamine H
3
receptor (K
i
=12430 nM).
High concentrations of Emedastine difumarate (1 and 10 ng/ml) significantly inhibits type 1 collagen production in normal human dermal fibroblasts.
Emedastine difumarate (1, 10, 100, 1000 nM) at concentrations of ≥ 10 nM inhibits CC chemokine-elicited eosinophil migration.
Emedastine difumarate (0.03, 0.1, 0.3 mg/kg; orally; pretreatment of 30 min) significantly suppresses histamine-induced scratching with 0.1 and 0.3 mg/kg but not 0.03 mg/kg.
Pretreatment with Emedastine difumarate (0.03, 0.1, 0.3 mg/kg; orally) significantly inhibits the scratching induced by substance P and leukotriene B.
Emedastine difumarate (0.3 mg/kg, p.o.) produces significant inhibition of passive peritoneal anaphylaxis in guinea-pigs.
Emedastine difumarate inhibits histamine-induced contractions of isolated ileum (IC
50
=6.1 nM).
| Animal Model: | Male ICR mice 5-6 weeks of age |
| Dosage: | 0.03, 0.1, 0.3 mg/kg |
| Administration: | Orally; 30 min before pruritogen injection |
| Result: | Significantly suppressed histamine-induced scratching with pretreatment of 0.1 and 0.3 mg/kg. |